As the beverage titan prepares to release its quarterly results on February 10, strategic portfolio adjustments are coming into focus....

With the latest earnings season now concluded, market participants are shifting their focus toward the long-term trajectory of Altria Group...

A fierce corporate battle is unfolding in the streaming sector, casting uncertainty over a landmark acquisition. Netflix's proposed $82.7 billion...

The timeline for a crucial investment decision regarding a major Australian rare earths development has been extended. Arafura Rare Earths,...

Applied Digital is accelerating its strategic evolution into a specialized provider of artificial intelligence infrastructure. The company's latest operational milestones,...

Exxon Mobil is accelerating its strategic pivot, bolstering its portfolio with significant investments in low-carbon energy solutions. The recent launch...

The investment case for cybersecurity leader CrowdStrike is currently being shaped by conflicting developments. Positive legal news provides some relief,...

The chapter for CureVac as an independent publicly traded company has officially closed. The biotech firm's shares have been removed...

Shares of Fossil Group have achieved a significant technical milestone, breaking through a major resistance level that market technicians closely...

Biotechnology firm Arcus Biosciences is executing a strategic overhaul of its clinical development portfolio after a significant late-2025 setback in...